Steris (STE) Revenue (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.16% |
| Dec 31, 2025 | 2.46% |
| Sep 30, 2025 | 4.97% |
| Jun 30, 2025 | -6.04% |
| Mar 31, 2025 | 8.02% |
| Dec 31, 2024 | 3.14% |
| Sep 30, 2024 | 3.86% |
| Jun 30, 2024 | -9.86% |
| Mar 31, 2024 | 9.38% |
| Dec 31, 2023 | 4.81% |
| Sep 30, 2023 | 4.63% |
| Jun 30, 2023 | -7.64% |
| Mar 31, 2023 | 15.18% |
| Dec 31, 2022 | 1.97% |
| Sep 30, 2022 | 3.74% |
| Jun 30, 2022 | -13.14% |
| Mar 31, 2022 | 0.14% |
| Dec 31, 2021 | 1.00% |
| Sep 30, 2021 | 23.60% |
| Jun 30, 2021 | 10.86% |
| Mar 31, 2021 | 7.99% |
| Dec 31, 2020 | 6.98% |
| Sep 30, 2020 | 13.04% |
| Jun 30, 2020 | -18.72% |
| Mar 31, 2020 | 6.29% |
| Dec 31, 2019 | 5.08% |
| Sep 30, 2019 | 5.75% |
| Jun 30, 2019 | -9.30% |
| Mar 31, 2019 | 10.34% |
| Dec 31, 2018 | 2.54% |
| Sep 30, 2018 | 6.29% |
| Jun 30, 2018 | -10.78% |